BioCentury
ARTICLE | Finance

IPO watch

Heavy demand for Euronext IPO by stent company Stentys

October 25, 2010 7:00 AM UTC

French coronary stent play Stentys S.A. (Euronext:STNT) priced its IPO and ex-U.S. private placement on Friday in an oversubscribed deal. The company raised €22.7 million ($31.7 million) through the sale of 1.9 million shares at €12, which is the midpoint of the company's proposed range of €10.80-€13.20.

The company's market cap is €87 million ($121.3 million)...